Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the ...

He is the head of HHS, and yet he continues to spout untested, unproven therapies and has only given a very lukewarm ...

Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell ...

The pharmaceutical industry faces environmental challenges. Green chemistry offers sustainable solutions to reduce waste and enhance drug discovery processes.

Some justices may be skeptical of a bid by GSK, Pfizer and others to overturn ruling allowing lawsuits to proceed over claims ...

She will join the Swiss pharma group after stepping down from her current role as senior vice president of discovery, preclinical and translational medicine at Merck, a position she has held since ...

Terminix®, a Rentokil Terminix company, announced today its annual list of the Top 50 Most Mosquito-Infested Cities in the U.S. based on 2024 service data from more than 300 branches ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.

Denise Bronner, Ph.D., makes the case for and against acquisitions for rejuvenating Big Pharma pipelines. She explains why ...

Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the ...

The 2023 decision to upend affirmative action, coupled with ongoing federal funding cuts, may threaten representation of Black leaders in the pharma industry.